2020
DOI: 10.1055/s-0040-1707139
|View full text |Cite
|
Sign up to set email alerts
|

Leveraging Framework Instability: A Journey from Energy Storage to Drug Delivery

Abstract: Amorphous pharmaceuticals often suffer from poor physical stability, which can negate their high solubility, fast dissolution rate, and better oral bioavailability vs. crystalline forms. This represents a major hurdle to processing, storage, and delivery of amorphous pharmaceuticals. Several approaches to addressing these problems have been pursued, but there is still a need for a general method for stabilizing the amorphous form. We describe a novel approach using a water-unstable metal-organic framework as a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Reduction of crystal size to the nanoscale regime inherently increases surface area (and surface energy), accompanied by increased rates of dissolution and absorption. 178 For example, APIs within the nanoscopic channels of silica-based matrices 179 and other biodegradable materials 180,181 have demonstrated significant increases in dissolution rates when compared with bulk (micronsized) counterparts for in vitro dissolution profiles. This approach to nanosized formulations may lead to tailored pharmacokinetic release profiles, increased target delivery and enhanced therapeutic efficacy.…”
Section: Why Do We Care About Confined Polymorphs?mentioning
confidence: 99%
“…Reduction of crystal size to the nanoscale regime inherently increases surface area (and surface energy), accompanied by increased rates of dissolution and absorption. 178 For example, APIs within the nanoscopic channels of silica-based matrices 179 and other biodegradable materials 180,181 have demonstrated significant increases in dissolution rates when compared with bulk (micronsized) counterparts for in vitro dissolution profiles. This approach to nanosized formulations may lead to tailored pharmacokinetic release profiles, increased target delivery and enhanced therapeutic efficacy.…”
Section: Why Do We Care About Confined Polymorphs?mentioning
confidence: 99%
“…Drug-delivery systems (DDSs) can be used to reduce the side effects, provide controlled release, and selectively target cancer-related diseases. Metal–organic frameworks (MOFs) have become promising candidates as DDSs due to their well-defined structures, tunable pore size, high surface area, high loading/release of guest compounds, amphiphilic internal microenvironment, and pH-dependent degradation under simulated physiological conditions. For example, the organic ligand 1,1′-biphenyl-4,4′-dicarboxylic acid (BPDC) has produced various porous frameworks: UiO-67 (Zr), UiO-67-(NH 2 ) 2 (Zr), bio-MOF-1 (Zn), and BPDC-Zr. ,, These materials have been employed as carriers for the intracellular delivery of chemotherapeutic agents such as pemetrexed, 5-fluorouracil (5-FU), and Ru-90, and other pharmaceutical compounds such as brimonidine, calcein, and α-cyano-4-hydroxycinnamic acid. ,, Specifically, 5-FU (∼6 wt %) and pemetrexed (∼18 wt %) were simultaneously loaded into UiO-67-(NH 2 ) 2 ; this MOF showed a pH-dependent release of both drugs in simulated physiological buffers . In addition, commercial BPs were employed recently to generate ALEN-, ZOLE-, and RISE-based coordination complexes and demonstrated suitable pH-dependent degradation, bone affinity [e.g., nano -Ca@ZOLE to hydroxyapatite (HA), 36%, 1 day], and cytotoxicity [e.g., nano -Ca@ALEN, relative cell viability (%RCV) = 38 ± 1% at 7.5 μM in 72 h] against the MDA-MB-231 cell line. However, these BP-based coordination complexes did not lead to porous materials able to encapsulate guest molecules. Furthermore, the reaction of benzene-1,4-bis­(bisphosphonic acid) (BBPA), the BP analogue of benzene-1,4-dicarboxylic acid (BDC), coordinated with Ca 2+ successfully led to BBPA-Ca form I, a 3D framework with channels (7 × 12 Å) large enough to encapsulate and release 5-FU (∼30 wt %) .…”
Section: Introductionmentioning
confidence: 99%
“…Supramolecular chemistry finds application in many areas of chemistry, 1 such as in drug delivery, 2 3 the design of artificial molecular motors, 4 and in catalysis. 5,6 The structures and functionalities of these compounds are mainly governed by non-covalent interactions (NCIs).…”
Section: Introductionmentioning
confidence: 99%